Top News: #BreastCancer

Here are the top read news for #BreastCancer: Drug combination therapy for estrogen-receptor–positive breast cancer passes critical step for worldwide approval: Building on earlier clinical trials, UCLA researchers have confirmed that the “breakthrough” drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the…

Top News: #Sleep

Here are the top read news for #Sleep: Electro-acupuncture may be effective in treating sleep disturbances in women with breast cancer: Poor sleep is particularly bothersome for breast cancer survivors experiencing nighttime hot flashes because it has been shown to increase levels of pain, fatigue, depression and anxiety. Although electro-acupuncture produced significant sleep improvements, researchers noted that…

Top News: #WomensHealth

Here are the top read news for #WomensHealth: Mastectomy followed by standard therapy improves survival in stage IV breast cancer patients: Surgery to remove the primary tumor in women diagnosed with stage IV breast cancer, followed by the standard combination of therapies, adds months to the patients’ lives, compared with standard therapy alone, an international…

Top News: #Cancer

Here are the top read news for #Cancer: Vitamin D levels connected to metastasis-associated protein, Stanford study finds: A preliminary study conducted primarily in laboratory mice indicates that breast cancer cells metastasize more readily when the animals have low levels of vitamin D: Read more Single dose of Trastuzumab initiated stronger immune response among certain breast…

Top News: #Cancer

Here are the top read news for #Cancer: Thyroid and breast cancer survivors at risk of the other malignancy: Women who survive either breast or thyroid cancer are at greater risk of developing the other type in the future as a secondary malignancy, says research published in Cancer Epidemiology, Biomarkers & Prevention: Read more  …